Laurel Wealth Advisors (North Carolina)’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-80
Closed -$2K 588
2022
Q3
$2K Hold
80
﹤0.01% 503
2022
Q2
$2K Hold
80
﹤0.01% 569
2022
Q1
$1K Hold
80
﹤0.01% 664
2021
Q4
$2K Hold
80
﹤0.01% 616
2021
Q3
$1K Sell
80
-48
-38% -$1.1K ﹤0.01% 665
2021
Q2
$3K Sell
128
-40
-24% -$1.12K ﹤0.01% 654
2021
Q1
$5K Hold
168
﹤0.01% 517
2020
Q4
$5K Sell
168
-80
-32% -$2.16K ﹤0.01% 491
2020
Q3
$6K Hold
248
﹤0.01% 422
2020
Q2
$4K Sell
248
-60
-19% -$789 ﹤0.01% 445
2020
Q1
$3K Sell
308
-140
-31% -$1.6K ﹤0.01% 458
2019
Q4
$6K Sell
448
-944
-68% -$11.4K ﹤0.01% 437
2019
Q3
$17K Sell
1,392
-1,834
-57% -$34K 0.01% 332
2019
Q2
$79K Sell
3,226
-828
-20% -$23.9K 0.03% 200
2019
Q1
$129K Buy
+4,054
New +$144K 0.05% 160

Other funds holding CVET

Laurel Wealth Advisors (North Carolina)'s CVET Position: Q4 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 80 shares — an estimated $2K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $129K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 80 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Covetrus, Inc. Common Stock position peaked at $129K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q4 2022, filed 7 Feb 2023.